当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析

灵康药业

(603669)

  

流通市值:29.93亿  总市值:29.93亿
流通股本:7.21亿   总股本:7.21亿

灵康药业(603669)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.16亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益91334.84万元,未分配利润-19196.30万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产148316.52万元,负债56981.68万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入76,861,627.55196,831,359.94150,665,541.41112,920,840.32
营业总成本94,759,740.05353,767,840.88255,792,111.55181,133,436.74
营业利润-17,208,207.06-148,980,712.18-93,993,126.65-67,764,256.37
利润总额-16,185,271.1-150,954,697.01-95,820,842.98-68,817,416.3
净利润-16,041,506.14-151,495,535.43-96,582,500.85-69,721,337.36
其他综合收益----
综合收益总额-16,041,506.14-151,495,535.43-96,582,500.85-69,721,337.36
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计746,729,106.24881,533,254.031,065,423,609.281,055,323,397.55
非流动资产合计736,436,070.57743,026,871.85737,603,011.64742,397,914.23
资产总计1,483,165,176.811,624,560,125.881,803,026,620.921,797,721,311.78
流动负债合计111,169,481.48243,110,445.1328,465,667.66303,726,672.42
非流动负债合计458,647,276.51450,407,533.29439,744,535.39432,317,058
负债合计569,816,757.99693,517,978.39768,210,203.05736,043,730.42
归属于母公司股东权益合计913,348,418.82931,042,147.491,034,816,417.871,061,677,581.36
股东权益合计913,348,418.82931,042,147.491,034,816,417.871,061,677,581.36
负债和股东权益合计1,483,165,176.811,624,560,125.881,803,026,620.921,797,721,311.78
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计81,853,145.87364,696,162.62260,896,973.39179,132,604.6
经营活动现金流出小计102,528,017.32402,570,690.71282,047,698.08204,959,742.9
经营活动产生的现金流量净额-20,674,871.45-37,874,528.09-21,150,724.69-25,827,138.3
投资活动现金流入小计87,327,929.611,033,234,479.65599,270,726.35461,885,459.19
投资活动现金流出小计6,110,083.961,085,131,822.82688,928,647.27594,145,279.27
投资活动产生的现金流量净额81,217,845.65-51,897,343.17-89,657,920.92-132,259,820.08
筹资活动现金流入小计12,000,000119,646,947.39118,646,944.44118,294,444.44
筹资活动现金流出小计102,043,486.29278,636,468.79122,774,585.4121,618,307.58
筹资活动产生的现金流量净额-90,043,486.29-158,989,521.4-4,127,640.96-3,323,863.14
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-29,500,512.09-248,761,392.66-114,936,286.57-161,410,821.52
期末现金及现金等价物余额282,930,347.78314,450,756.82448,275,862.91401,801,327.96
TOP↑